These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 7927802

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.
    Kotloff KL, Noriega F, Losonsky GA, Sztein MB, Wasserman SS, Nataro JP, Levine MM.
    Infect Immun; 1996 Nov; 64(11):4542-8. PubMed ID: 8890204
    [Abstract] [Full Text] [Related]

  • 3. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
    Noriega FR, Losonsky G, Wang JY, Formal SB, Levine MM.
    Infect Immun; 1996 Jan; 64(1):23-7. PubMed ID: 8557344
    [Abstract] [Full Text] [Related]

  • 4. Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine.
    Noriega FR, Losonsky G, Lauderbaugh C, Liao FM, Wang JY, Levine MM.
    Infect Immun; 1996 Aug; 64(8):3055-61. PubMed ID: 8757833
    [Abstract] [Full Text] [Related]

  • 5. [Construction and characterization of a live attenuated Shigella flexneri 2a vaccine strain, sf301 Delta virG and dsbA33G].
    Yang XF, Zhou L, Zheng J, Si LS, Wang YL.
    Wei Sheng Wu Xue Bao; 2005 Oct; 45(5):748-52. PubMed ID: 16342769
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
    Ranallo RT, Thakkar S, Chen Q, Venkatesan MM.
    Vaccine; 2007 Mar 08; 25(12):2269-78. PubMed ID: 17229494
    [Abstract] [Full Text] [Related]

  • 9. Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.
    Koprowski H, Levine MM, Anderson RJ, Losonsky G, Pizza M, Barry EM.
    Infect Immun; 2000 Sep 08; 68(9):4884-92. PubMed ID: 10948101
    [Abstract] [Full Text] [Related]

  • 10. Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates.
    Ranallo RT, Fonseka S, Boren TL, Bedford LA, Kaminski RW, Thakkar S, Venkatesan MM.
    Vaccine; 2012 Jul 20; 30(34):5159-71. PubMed ID: 22658966
    [Abstract] [Full Text] [Related]

  • 11. Virulence phenotype and genetic characteristics of the T32-ISTRATI Shigella flexneri 2a vaccine strain.
    Venkatesan M, Fernandez-Prada C, Buysse JM, Formal SB, Hale TL.
    Vaccine; 1991 May 20; 9(5):358-63. PubMed ID: 1872021
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.
    Kärnell A, Cam PD, Verma N, Lindberg AA.
    Vaccine; 1993 May 20; 11(8):830-6. PubMed ID: 8356844
    [Abstract] [Full Text] [Related]

  • 14. Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans.
    Kotloff KL, Noriega FR, Samandari T, Sztein MB, Losonsky GA, Nataro JP, Picking WD, Barry EM, Levine MM.
    Infect Immun; 2000 Mar 20; 68(3):1034-9. PubMed ID: 10678904
    [Abstract] [Full Text] [Related]

  • 15. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.
    DeLaine BC, Wu T, Grassel CL, Shimanovich A, Pasetti MF, Levine MM, Barry EM.
    Pathog Dis; 2016 Jul 20; 74(5):. PubMed ID: 27106253
    [Abstract] [Full Text] [Related]

  • 16. Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. I. Construction of vaccine candidate strains with retained invasiveness but reduced intracellular multiplication.
    Linde K, Dentchev V, Bondarenko V, Marinova S, Randhagen B, Bratoyeva M, Tsvetanov Y, Romanova Y.
    Vaccine; 1990 Feb 20; 8(1):25-9. PubMed ID: 2180230
    [Abstract] [Full Text] [Related]

  • 17. DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin.
    Anderson RJ, Pasetti MF, Sztein MB, Levine MM, Noriega FR.
    Vaccine; 2000 Apr 28; 18(21):2193-202. PubMed ID: 10717338
    [Abstract] [Full Text] [Related]

  • 18. Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208.
    Kotloff KL, Pasetti MF, Barry EM, Nataro JP, Wasserman SS, Sztein MB, Picking WD, Levine MM.
    J Infect Dis; 2004 Nov 15; 190(10):1745-54. PubMed ID: 15499528
    [Abstract] [Full Text] [Related]

  • 19. Construction and characterization of virG (icsA)-deleted Escherichia coli K12-Shigella flexneri hybrid vaccine strains.
    Alexander WA, Hartman AB, Oaks EV, Venkatesan MM.
    Vaccine; 1996 Aug 15; 14(11):1053-61. PubMed ID: 8879102
    [Abstract] [Full Text] [Related]

  • 20. Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.
    Formal SB, Hale TL, Kapfer C, Cogan JP, Snoy PJ, Chung R, Wingfield ME, Elisberg BL, Baron LS.
    Infect Immun; 1984 Nov 15; 46(2):465-9. PubMed ID: 6389344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.